dextroamphetamine has been researched along with Anochlesia in 72 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Evaluation of (+)-22a in animal models of schizophrenia-related behaviors revealed that it had a desirable activity profile, as it reduced d-amphetamine-stimulated hyperlocomotion in the open field test, it restored d-amphetamine-disrupted prepulse inhibition, it induced cognitive improvements in the novel object recognition memory test in NR1-KD animals, and it produced very little catalepsy relative to haloperidol." | 3.83 | Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models. ( Cheng, J; Giguere, PM; Huang, XP; Kozikowski, AP; McCorvy, JD; Pogorelov, VM; Rodriguiz, RM; Roth, BL; Schmerberg, CM; Wetsel, WC; Zhu, H, 2016) |
| " We studied the effect of SB-271046 [5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide], a specific 5-HT(6) receptor antagonist, in three models for the positive symptoms of schizophrenia---D-amphetamine-induced hyperactivity, and D-amphetamine- or phencyclidine (PCP)-disrupted prepulse inhibition (PPI)." | 3.71 | Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia. ( Arnt, J; Didriksen, M; Pouzet, B, 2002) |
| " Finally, minaprine does not antagonize either oxotremorine-induced tremors or physiostigmine-induced lethality." | 3.66 | Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. ( Bizière, K; Kan, JP; Muyard, JP; Roncucci, R; Souilhac, J, 1982) |
| " The compound antagonized amphetamine-induced stereotyped behavior in rats, amphetamine toxicity in aggregated mice and apomorphine-induced emesis in dogs." | 3.65 | The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug. ( Herr, F; Voith, K, 1975) |
| "Sertraline (10 mg/kg ip) was injected either acutely, or over 5 days of repeated treatment." | 1.38 | Effects of sertraline on experimental mouse models of psychosis. ( Bilge, U; Erol, K, 2012) |
| "Propensity to induce catalepsy, predictive of occurrence of extrapyramidal side effects, was inversely related to affinity at 5-HT1A receptors." | 1.34 | Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. ( Auclair, A; Bardin, L; Depoortère, R; Kleven, MS; Koek, W; Newman-Tancredi, A; Prinssen, EP, 2007) |
| "Apomorphine stereotypy was not potentiated or antagonised by pretreatment with 7." | 1.34 | Effects of dextromethorphan on dopamine dependent behaviours in rats. ( Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM, 2007) |
| "Mild catalepsy was observed at 30 mg/kg, being more pronounced at 50 mg/kg and 100 mg/kg." | 1.33 | Atypical antipsychotic profile of flunarizine in animal models. ( Dall'Igna, OP; de Oliveira, RV; Fett, P; Gomes, MW; Lara, DR; Mantese, CE; Schuh, J; Souza, DO; Tort, AB, 2005) |
| " However, limited peptide stability and oral bioavailability have prevented these compounds from being developed as relevant pharmaceuticals." | 1.33 | Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. ( Dix, TA; Hadden, MK; Kokko, KP; Mazella, J; Orwig, KS, 2005) |
| "Papaverine is found to inhibit conditioned avoidance responding in rats and mice and to inhibit PCP- and amphetamine-stimulated locomotor activity in rats." | 1.33 | Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. ( Chambers, L; Chapin, DS; Harms, JF; Lebel, LA; McCarthy, SA; Menniti, FS; Schmidt, CJ; Shrikhande, A; Siuciak, JA; Wong, S, 2006) |
| "flupirtine." | 1.30 | Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs. ( Pergande, G; Schmidt, WJ; Schuster, G; Wacker, E, 1997) |
| "Haloperidol, which was used as a reference compound for classical DA antagonists, showed clear activity in all four models at low doses (0." | 1.28 | The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437. ( Bohus, BG; Horn, AS; Tepper, PG; Timmerman, W, 1990) |
| "Similarly, catalepsy induced by (-)-sulpiride (40 mg/kg, i." | 1.27 | Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats. ( Wambebe, C, 1987) |
| " SHPGE2, PGE2, and C did not cause catalepsy and did not show statistically significant dose-response antagonism of rotational behavior at less than toxic doses." | 1.26 | Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat. ( Bloss, JL; Singer, GH, 1978) |
| "2." | 1.26 | The interaction of clonidine with dopamine-dependent behaviour in rodents. ( Jenner, PG; Marsden, CD; Pycock, CJ, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (61.11) | 18.7374 |
| 1990's | 12 (16.67) | 18.2507 |
| 2000's | 12 (16.67) | 29.6817 |
| 2010's | 4 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J | 1 |
| Giguere, PM | 1 |
| Schmerberg, CM | 1 |
| Pogorelov, VM | 1 |
| Rodriguiz, RM | 1 |
| Huang, XP | 1 |
| Zhu, H | 1 |
| McCorvy, JD | 1 |
| Wetsel, WC | 1 |
| Roth, BL | 1 |
| Kozikowski, AP | 1 |
| Holly, EN | 1 |
| Ebrecht, B | 1 |
| Prus, AJ | 1 |
| Quinnell, TG | 1 |
| Smith, IE | 1 |
| Bilge, U | 1 |
| Erol, K | 1 |
| Tomić, M | 1 |
| Kundaković, M | 1 |
| Butorović, B | 1 |
| Vasilev, V | 1 |
| Dragović, D | 1 |
| Roglić, G | 1 |
| Ignjatović, DJ | 1 |
| Soskić, V | 1 |
| Kostić-Rajacić, S | 1 |
| Tort, AB | 1 |
| Dall'Igna, OP | 1 |
| de Oliveira, RV | 1 |
| Mantese, CE | 1 |
| Fett, P | 1 |
| Gomes, MW | 1 |
| Schuh, J | 1 |
| Souza, DO | 1 |
| Lara, DR | 1 |
| Izzo, E | 1 |
| Sanna, PP | 1 |
| Koob, GF | 1 |
| Hadden, MK | 1 |
| Orwig, KS | 1 |
| Kokko, KP | 1 |
| Mazella, J | 1 |
| Dix, TA | 1 |
| Siuciak, JA | 2 |
| Chapin, DS | 2 |
| Harms, JF | 1 |
| Lebel, LA | 1 |
| McCarthy, SA | 2 |
| Chambers, L | 1 |
| Shrikhande, A | 1 |
| Wong, S | 1 |
| Menniti, FS | 1 |
| Schmidt, CJ | 1 |
| Guanowsky, V | 1 |
| Brown, J | 1 |
| Chiang, P | 1 |
| Marala, R | 1 |
| Patterson, T | 1 |
| Seymour, PA | 1 |
| Swick, A | 1 |
| Iredale, PA | 1 |
| Kanes, SJ | 1 |
| Tokarczyk, J | 1 |
| Siegel, SJ | 1 |
| Bilker, W | 1 |
| Abel, T | 1 |
| Kelly, MP | 1 |
| Bardin, L | 1 |
| Auclair, A | 1 |
| Kleven, MS | 1 |
| Prinssen, EP | 1 |
| Koek, W | 1 |
| Newman-Tancredi, A | 1 |
| Depoortère, R | 1 |
| Gaikwad, RV | 1 |
| Gaonkar, RK | 1 |
| Jadhav, SA | 1 |
| Thorat, VM | 1 |
| Jadhav, JH | 1 |
| Balsara, JJ | 1 |
| Nudelman, A | 1 |
| Gil-Ad, I | 1 |
| Shpaisman, N | 1 |
| Terasenko, I | 1 |
| Ron, H | 1 |
| Savitsky, K | 1 |
| Geffen, Y | 1 |
| Weizman, A | 1 |
| Rephaeli, A | 1 |
| Stoff, DM | 1 |
| Gale, K | 1 |
| Costall, B | 6 |
| Fortune, DH | 1 |
| Naylor, RJ | 6 |
| Nohria, V | 1 |
| Arribas, E | 1 |
| Vega, S | 1 |
| Benito, C | 1 |
| Fernandez-Tome, MP | 1 |
| del Rio, J | 1 |
| Carey, RJ | 1 |
| Bizière, K | 1 |
| Kan, JP | 1 |
| Souilhac, J | 1 |
| Muyard, JP | 1 |
| Roncucci, R | 1 |
| Kales, A | 1 |
| Cadieux, RJ | 1 |
| Soldatos, CR | 1 |
| Bixler, EO | 1 |
| Schweitzer, PK | 1 |
| Prey, WT | 1 |
| Vela-Bueno, A | 1 |
| Borlongan, CV | 1 |
| Martinez, R | 1 |
| Shytle, RD | 1 |
| Freeman, TB | 1 |
| Cahill, DW | 1 |
| Sanberg, PR | 1 |
| Lyon, M | 1 |
| McClure, WO | 1 |
| Ouagazzal, A | 1 |
| Nieoullon, A | 1 |
| Amalric, M | 1 |
| Ogren, SO | 1 |
| Rosén, L | 1 |
| Fuxe, K | 1 |
| Schmidt, WJ | 1 |
| Schuster, G | 1 |
| Wacker, E | 1 |
| Pergande, G | 1 |
| Simansky, KJ | 1 |
| Baker, G | 1 |
| Kachelries, WJ | 1 |
| Hood, H | 1 |
| Romano, AG | 1 |
| Harvey, JA | 1 |
| Hauber, W | 1 |
| Lutz, S | 1 |
| Münkle, M | 1 |
| Rupprecht, R | 1 |
| Koch, M | 1 |
| Montkowski, A | 1 |
| Lancel, M | 1 |
| Faulhaber, J | 1 |
| Harting, J | 1 |
| Spanagel, R | 1 |
| Maj, J | 2 |
| Rogóz, Z | 1 |
| Skuza, G | 1 |
| Pouzet, B | 2 |
| Didriksen, M | 2 |
| Arnt, J | 2 |
| Prieto, J | 1 |
| Moragues, J | 1 |
| Spickett, RG | 1 |
| Vega, A | 1 |
| Colombo, M | 1 |
| Salazar, W | 1 |
| Roberts, DJ | 1 |
| Di Chiara, G | 1 |
| Vargiu, L | 1 |
| Porceddu, ML | 1 |
| Longoni, R | 1 |
| Mulas, A | 1 |
| Gessa, GL | 1 |
| Voith, K | 4 |
| Bruderlein, FT | 3 |
| Humber, LG | 4 |
| Sideridis, N | 1 |
| Asselin, AA | 1 |
| Press, JB | 1 |
| Hofmann, CM | 1 |
| Eudy, NH | 1 |
| Fanshawe, WJ | 1 |
| Day, IP | 1 |
| Greenblatt, EN | 1 |
| Safir, SR | 1 |
| Bloss, JL | 1 |
| Singer, GH | 1 |
| Hui, SC | 1 |
| Metcalf, G | 1 |
| Gough, AL | 2 |
| Olley, JE | 2 |
| Pycock, CJ | 2 |
| Jenner, PG | 1 |
| Marsden, CD | 1 |
| Philipp, AH | 2 |
| Götz, M | 1 |
| Carter, CJ | 1 |
| Herr, F | 1 |
| Janssen, PA | 1 |
| Niemegeers, CJ | 1 |
| Schellekens, KH | 1 |
| Lenaerts, FM | 1 |
| Wauquier, A | 1 |
| Corral, C | 1 |
| Lissavetzky, J | 1 |
| Valdeolmillos, A | 1 |
| Bravo, L | 1 |
| Darias, V | 1 |
| Sánchez Mateo, C | 1 |
| Gustafsson, B | 1 |
| Christensson, E | 1 |
| Timmerman, W | 1 |
| Tepper, PG | 1 |
| Bohus, BG | 1 |
| Horn, AS | 1 |
| Wambebe, C | 2 |
| Sokomba, E | 1 |
| Campbell, W | 1 |
| Clark, MS | 1 |
| Mitchell, PJ | 1 |
| Needham, PL | 1 |
| Semple, JM | 1 |
| Rebec, GV | 1 |
| Centore, JM | 1 |
| White, LK | 1 |
| Alloway, KD | 1 |
| Sayers, AC | 3 |
| Handley, SL | 2 |
| Johnson, AM | 1 |
| Vigouret, JM | 1 |
| Loew, DM | 1 |
| Pettit, JC | 1 |
| Weissman, A | 1 |
| Johnson, DN | 1 |
| Funderburk, WH | 1 |
| Ward, JW | 1 |
| Cashin, CH | 1 |
| Sutton, S | 1 |
| Papeschi, R | 1 |
| Randrup, A | 2 |
| Sowińska, H | 1 |
| Baran, L | 1 |
| Sarnek, J | 1 |
| Tseng, LF | 1 |
| Loh, HH | 1 |
| Cools, AR | 1 |
| Fog, R | 1 |
| Pakkenberg, H | 1 |
| Boissier, JR | 1 |
| Simon, P | 1 |
| Giudicelli, JF | 1 |
| Morpurgo, C | 1 |
| Theobald, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treating Comorbid Depression of Patients With Narcolepsy by Intermittent Theta Burst Stimulation: A Preliminary Study[NCT05884112] | 105 participants (Anticipated) | Interventional | 2023-02-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
72 other studies available for dextroamphetamine and Anochlesia
| Article | Year |
|---|---|
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.
Topics: Animals; Brain; Catalepsy; Central Nervous System Stimulants; Cognition; Dextroamphetamine; Drug Des | 2016 |
The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Central Nervous System Stimulants; Clo | 2011 |
Narcolepsy, idiopathic hypersomnolence and related conditions.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Catalepsy; Central Nervous System Stimulants | 2011 |
Effects of sertraline on experimental mouse models of psychosis.
Topics: Animals; Antidepressive Agents; Apomorphine; Catalepsy; Dextroamphetamine; Disease Models, Animal; D | 2012 |
Pharmacological evaluation of 5-[2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl]-1,3-dihydro-benzimidazole-2-thione as a potential atypical antipsychotic agent.
Topics: Animals; Antipsychotic Agents; Benzimidazoles; Catalepsy; Central Nervous System Stimulants; Dextroa | 2003 |
Atypical antipsychotic profile of flunarizine in animal models.
Topics: Administration, Oral; Animals; Catalepsy; Dextroamphetamine; Disease Models, Animal; Dizocilpine Mal | 2005 |
Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Corticotropin | 2005 |
Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
Topics: Animals; Antipsychotic Agents; Area Under Curve; Arginine; Biological Availability; Catalepsy; Centr | 2005 |
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Central Nervous System Stimulants; Cor | 2006 |
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Dextro | 2007 |
Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acoustic Stimulation; Animals; Antipsychotic Agents; Behavior, | 2007 |
Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Central Nervous Syst | 2007 |
Effects of dextromethorphan on dopamine dependent behaviours in rats.
Topics: Animals; Antitussive Agents; Apomorphine; Behavior, Animal; Catalepsy; Dextroamphetamine; Dextrometh | 2007 |
A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Biological Availability; Catalepsy; Dextroamphe | 2008 |
beta-Phenylethylamine reversal of chlorpromazine-induced activation of striatal tyrosine hydroxylase and catalepsy.
Topics: Animals; Apomorphine; Catalepsy; Caudate Nucleus; Chlorpromazine; Dextroamphetamine; Humans; Male; P | 1981 |
Behavioural actions of neuroleptics are not reduced by hypophysectomy.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Dextroamphetamine; Humans; Hypophysectom | 1982 |
Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity.
Topics: Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Antipsychotic Agents; Benzothiadiazines; Bra | 1983 |
Differential effects of limbic versus striatal dopamine loss on motoric function.
Topics: Animals; Catalepsy; Corpus Striatum; Dextroamphetamine; Dopamine; Humans; Hydroxydopamines; Limbic S | 1983 |
Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Catalepsy; Dextroamphetamine; Drug Evaluation; Dru | 1982 |
Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics.
Topics: Adolescent; Adult; Aged; Catalepsy; Dextroamphetamine; Electroencephalography; Female; Hallucination | 1982 |
Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery.
Topics: Animals; Catalepsy; Cerebral Arteries; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Antago | 1995 |
Investigations of fetal development models for prenatal drug exposure and schizophrenia. Prenatal d-amphetamine effects upon early and late juvenile behavior in the rat.
Topics: Animals; Behavior, Animal; Body Weight; Catalepsy; Dextroamphetamine; Disease Models, Animal; Extinc | 1994 |
Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats.
Topics: Animals; Benzazepines; Catalepsy; Dextroamphetamine; Dizocilpine Maleate; Dopamine D2 Receptor Antag | 1993 |
The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
Topics: Animals; Binding, Competitive; Brain; Catalepsy; Corpus Striatum; Dextroamphetamine; Dose-Response R | 1994 |
Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs.
Topics: Aminopyridines; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Dextroamphetamine; Dose- | 1997 |
Prenatal exposure to cocaine reduces dopaminergic D1-mediated motor function but spares the enhancement of learning by amphetamine in rabbits.
Topics: Acoustic Stimulation; Animals; Association Learning; Benzazepines; Blinking; Catalepsy; Cocaine; Con | 1998 |
The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats.
Topics: Animals; Benzazepines; Brain Mapping; Catalepsy; Dextroamphetamine; Dopamine; Dopamine Antagonists; | 1998 |
Assessment of neuroleptic-like properties of progesterone.
Topics: Animals; Antipsychotic Agents; Anxiety; Avoidance Learning; Catalepsy; Dextroamphetamine; Dopamine U | 1999 |
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopam | 1999 |
Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia.
Topics: Animals; Catalepsy; Central Nervous System Stimulants; Clozapine; Dextroamphetamine; Dose-Response R | 2002 |
Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia.
Topics: Animals; Antipsychotic Agents; Catalepsy; Central Nervous System Stimulants; Dextroamphetamine; Dose | 2002 |
Synthesis and pharmacological properties of a series of antidopaminergic piperidyl benzamides.
Topics: Animals; Apomorphine; Benzamides; Catalepsy; Depression, Chemical; Dextroamphetamine; Dopamine; Fema | 1977 |
Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Analgesics, Opioid; Animals; Apomorphine; Catalep | 1977 |
Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Butaclamol; Catalepsy; Conditioning, Psychologica | 1978 |
Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Butaclamol; Catalepsy; Dextroamphetamine; Dibenzo | 1978 |
10-(Alkylamino)-4H-thieno[3,4-b][1,5]benzodiazepines. A novel class of potential neuroleptic agents.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dextroamphetamine; E | 1979 |
Editorial: Narcolepsy and cataplexy.
Topics: Brain; Catalepsy; Catecholamines; Clomipramine; Dextroamphetamine; Humans; Metabolism, Inborn Errors | 1975 |
Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.
Topics: Animals; Avoidance Learning; Behavior, Animal; Catalepsy; Clozapine; Dextroamphetamine; Fluphenazine | 1978 |
A study of the changes in motor behaviour caused by TRH on intracerebral injection.
Topics: Animals; Brain; Catalepsy; Chloral Hydrate; Dextroamphetamine; Dopamine; Dose-Response Relationship, | 1979 |
delta9-Tetrahydrocannabinol and the extrapyramidal system.
Topics: Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Caudate Nucleus; Dextroamphetamine; Dronabinol; | 1977 |
The interaction of clonidine with dopamine-dependent behaviour in rodents.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Clonidine; Corpus Striatum; Dextroamphetamine; Do | 1977 |
Catalepsy induced by intrastriatal injections of delta9-THC and 11-OH-delta9-THC in the rat.
Topics: Animals; Catalepsy; Corpus Striatum; Dextroamphetamine; Dronabinol; Drug Interactions; Humans; Injec | 1978 |
Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol.
Topics: Aggression; Animals; Avoidance Learning; Butaclamol; Catalepsy; Dextroamphetamine; Dibenzocyclohepte | 1979 |
Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol.
Topics: Aggression; Animals; Avoidance Learning; Butaclamol; Catalepsy; Dextroamphetamine; Dibenzocyclohepte | 1979 |
Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine.
Topics: Animals; Apomorphine; Brain; Catalepsy; Dextroamphetamine; Dopamine; Drug Interactions; Haloperidol; | 1979 |
The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Chlorpromazine; | 1975 |
Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Clozapine; Dextroamphetamine; Dibenzazepines; Dos | 1975 |
Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Benzimidazoles; Blepharoptosis; Body Tem | 1975 |
Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
Topics: Animals; Antipsychotic Agents; Body Temperature; Catalepsy; Dextroamphetamine; Dopamine Agents; Expl | 1992 |
Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Dextroamphetamine; Dopamine; Exploratory | 1990 |
The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Dextroamphetamine; D | 1990 |
Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
Topics: Aging; Animals; Antipsychotic Agents; Benzamides; Catalepsy; Chickens; Dextroamphetamine; Fenclonine | 1987 |
Some behavioural and EEG effects of ascorbic acid in rats.
Topics: Animals; Ascorbic Acid; Behavior, Animal; Catalepsy; Dextroamphetamine; Dose-Response Relationship, | 1986 |
BRL 20596, a novel anilide with central dopamine antagonist activity.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Brain Chemistry; Catalepsy; Dextroamphet | 1986 |
Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs.
Topics: Animals; Ascorbic Acid; Behavior, Animal; Catalepsy; Dextroamphetamine; Drug Synergism; Haloperidol; | 1985 |
A study of the role of catecholamines in the response to various central stimulants.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Catecholamines; Central Nervous System Stimulants; Coc | 1973 |
The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
Topics: Amygdala; Animals; Behavior; Benzoates; Butyrophenones; Catalepsy; Dextroamphetamine; Dibenzazepines | 1974 |
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromine; Catalepsy; Dextroamphe | 1974 |
Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Caudate Nucleus; Cerebral Cortex; Corpus | 1974 |
Psychopharmacological effects of thiothixene and related compounds.
Topics: Animals; Apomorphine; Avoidance Learning; Body Temperature; Catalepsy; Chlorpromazine; Dextroampheta | 1968 |
Preclinical evaluation of AHR-2244 a new psychotherapeutic agent.
Topics: Animals; Avoidance Learning; Benzoates; Catalepsy; Cats; Corpus Striatum; Dextroamphetamine; Dopamin | 1974 |
Mesolimbic involvement with behavioural effects indicating antipsychotic activity.
Topics: Animals; Behavior, Animal; Catalepsy; Dextroamphetamine; Dibenzothiazepines; Dose-Response Relations | 1974 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain | 1973 |
The role of amphetamine metabolism in the alpha-methyl-p-tyrosine-d-amphetamine catalepsy.
Topics: Animals; Antidepressive Agents; Catalepsy; Desipramine; Dextroamphetamine; Dibenzocycloheptenes; Eth | 1973 |
Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; De | 1973 |
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
Topics: Amantadine; Animals; Apomorphine; Blood Pressure; Body Temperature; Brain Chemistry; Catalepsy; Chlo | 1974 |
Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
Topics: Amphetamine; Animals; Apomorphine; Aporphines; Catalepsy; Dextroamphetamine; Dopamine; Haloperidol; | 1974 |
Neurochemical correlates of the waltzing-shaker syndrome in the Varitint-waddler mouse.
Topics: Animals; Autoradiography; Behavior, Animal; Carbon Isotopes; Catalepsy; Dextroamphetamine; Dihydroxy | 1972 |
Interaction of anticholinergic agents with -methyl-p-tyrosine and (+)-amphetamine.
Topics: Animals; Atropine; Catalepsy; Dextroamphetamine; Drug Hypersensitivity; Drug Synergism; Humans; Meth | 1972 |
Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour.
Topics: Aggression; Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Cerebral Cortex; Dextroamphetamine; | 1970 |
[Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
Topics: Animals; Apomorphine; Blepharoptosis; Bretylium Compounds; Catalepsy; Central Nervous System; Chlorp | 1968 |
Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature; Catalepsy | 1964 |